Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | chemokine (C-C motif) receptor 4 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | growth hormone secretagogue receptor type 1 | chemokine (C-C motif) receptor 4 | 360 aa | 316 aa | 22.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0031 | 0.043 | 0.043 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.043 | 0.0537 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0037 | 0.0614 | 0.0767 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0239 | 0.6442 | 0.8052 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0614 | 0.0767 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0239 | 0.646 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0037 | 0.0614 | 0.5 |
Schistosoma mansoni | glutaminase | 0.0293 | 0.8 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0037 | 0.0614 | 0.0614 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0037 | 0.0614 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0614 | 0.0767 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0037 | 0.0614 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0031 | 0.043 | 0.043 |
Loa Loa (eye worm) | hypothetical protein | 0.0098 | 0.2376 | 0.297 |
Mycobacterium leprae | Probable lipase LipE | 0.0037 | 0.0614 | 0.5 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0031 | 0.043 | 0.043 |
Mycobacterium ulcerans | glutaminase | 0.0293 | 0.8 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0037 | 0.0614 | 0.5 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0037 | 0.0614 | 0.0767 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0037 | 0.0614 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.043 | 0.0537 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0098 | 0.2376 | 0.297 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0614 | 0.0767 |
Brugia malayi | beta-lactamase family protein | 0.0037 | 0.0614 | 0.0767 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0614 | 0.0767 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0098 | 0.2376 | 0.297 |
Schistosoma mansoni | hypothetical protein | 0.0135 | 0.343 | 0.4288 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0037 | 0.0614 | 0.0767 |
Loa Loa (eye worm) | beta-lactamase | 0.0037 | 0.0614 | 0.0767 |
Loa Loa (eye worm) | glutaminase | 0.0293 | 0.8 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0031 | 0.043 | 0.043 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0031 | 0.043 | 0.0537 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0135 | 0.343 | 0.343 |
Trichomonas vaginalis | glutaminase, putative | 0.0293 | 0.8 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.043 | 0.0537 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0067 | 0.1475 | 0.1844 |
Brugia malayi | MH2 domain containing protein | 0.0239 | 0.6442 | 0.8052 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0614 | 0.0767 |
Schistosoma mansoni | thyroid hormone receptor | 0.0146 | 0.3743 | 0.4679 |
Schistosoma mansoni | hypothetical protein | 0.0067 | 0.1475 | 0.1844 |
Onchocerca volvulus | 0.0053 | 0.1062 | 1 | |
Echinococcus granulosus | GPCR family 2 | 0.0031 | 0.043 | 0.043 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0239 | 0.6442 | 0.8052 |
Loa Loa (eye worm) | glutaminase 2 | 0.0293 | 0.8 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0037 | 0.0614 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0031 | 0.043 | 0.0537 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0031 | 0.043 | 0.043 |
Schistosoma mansoni | thyroid hormone receptor | 0.0146 | 0.3743 | 0.4679 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0135 | 0.343 | 0.343 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.1475 | 0.1844 |
Brugia malayi | beta-lactamase family protein | 0.0037 | 0.0614 | 0.0767 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0037 | 0.0614 | 0.0767 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0037 | 0.0614 | 0.0614 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0031 | 0.043 | 0.0537 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.043 | 0.0537 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.043 | 0.0537 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1062 | 0.1327 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0053 | 0.1062 | 0.1327 |
Toxoplasma gondii | ABC1 family protein | 0.0037 | 0.0614 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0098 | 0.2376 | 0.297 |
Brugia malayi | glutaminase DH11.1 | 0.0293 | 0.8 | 1 |
Brugia malayi | beta-lactamase | 0.0037 | 0.0614 | 0.0767 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0614 | 0.0767 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0146 | 0.3743 | 0.3743 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 7.8 | Antagonist activity at human recombinant CCR4 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay | ChEMBL. | 23409871 |
Kd (binding) | = 5.9 | Antagonist activity at CCR4 receptor in human whole blood assessed as F-actin polymerization after 30 mins by FACS-based flow cytometric analysis | ChEMBL. | 23409871 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.